Skip to main content
. 2013 Apr 8;4(5):441–445. doi: 10.1021/ml4000673

Table 2. Structure–Activity Investigations of the 2-Fluoro Alkyne Agonists.

graphic file with name ml-2013-000673_0007.jpg

      pEC50 (efficacy, %)
     
compd R1 X hFFA1, calciuma hFFA4, BRETb ClogPc LEd LLEe
9 2-Me H 7.34 ± 0.07 (103) 5.84 ± 0.01 (103) 5.04 0.50 2.30
10 2-Me F 7.48 ± 0.03 (107) 5.80 ± 0.03 (98) 5.18 0.49 2.30
11 3-Me F 7.65 ± 0.03 (100) 5.41 ± 0.07 (124) 5.18 0.50 2.47
12 2-Me, 5-CN F 7.77 ± 0.03 (104) 5.02 ± 0.04 (123) 4.62 0.46 3.15
13 2-CF2H, 5-F F 7.74 ± 0.04 (97) 5.93 ± 0.04 (117) 5.02 0.44 2.72
14 3,5-Cl F 7.42 ± 0.07 (99) 5.50 ± 0.25 (90) 6.11 0.46 1.31
15 2-CH2Ms F 5.84 ± 0.02 (97) n.a. 2.67 0.33 3.17
16 3-CH2Ms F 5.71 ± 0.02 (104) 4.19 ± 0.06 (26) 2.67 0.33 3.04
17 2-CH2O(CH2)2Ms F 6.21 ± 0.03 (94) n.a. 3.33 0.31 2.88
18 3-CH2O(CH2)2Ms F 6.44 ± 0.03 (93) n.a. 3.33 0.33 3.11
19 2-CH2O(CH2)3Ms F 6.14 ± 0.04 (92) n.a. 3.59 0.30 2.55
20 3-CH2O(CH2)3Ms F 6.43 ± 0.04 (83) n.a. 3.59 0.31 2.84
21 2-CH2CN H 7.70 ± 0.04 (103) 6.11 ± 0.06 (99) 3.96 0.48 3.76
22 2-CH2CN F 8.21 ± 0.03 (102) 6.03 ± 0.06 (98) 4.11 0.49 4.10
23 3-CH2CN F 7.13 ± 0.03 (104) 5.41 ± 0.07 (115) 4.11 0.42 3.02
24 2-CH2CH2CN F 7.74 ± 0.04 (97) 5.86 ± 0.00 (114) 4.25 0.44 3.50
a

Efficacy is given as % response relative to 10 μM TUG-20.19

b

Efficacy is given as % response relative to 9; n.a. = no activity (pEC50 < 4).14

c

Calculated by BioByte’s algorithm as implemented in ChemBioDraw Ultra 12.0 (ClogP option).

d

LE = RTln KD, presuming that EC50KD. Values are given in kcal mol–1 per non-hydrogen atom.17

e

LLE = pEC50 – ClogP.18

HHS Vulnerability Disclosure